LSN-34161-94833
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 551 / MN
- Registered
- 2021-06-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-13
Dose 1 — Pfizer-BioNTech
-
2021-06-20
Registered in v-safe
- 2021-06-20
- 2021-06-27
-
2021-07-05
Dose 2 — Pfizer-BioNTech
-
2021-07-07
Survey response — days 1–6 daily, dose 2MedDRA: Paranasal sinus discomfort, Respiratory tract congestion — Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, sinus pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-08
- 2021-07-09
- 2021-07-11
- 2021-07-28
- 2021-08-02
- 2021-08-09
- 2021-08-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-13 | Pfizer-BioNTech | No |
| 2 | 2021-07-05 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Congestion, sinus pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release